Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Predictors for lower quality of life in the HAART era among HIV-infected men

Article Abstract:

A study was conducted to identify the predictors of lower Quality of Life (QOL) and to help assess important and alterable factors for possible interventions to maximize patients' QOL among highly active antiretroviral therapy (HAART). Many variables could serve as predictors for QOL and maximizing QOL requires targeted and comprehensive interventions for modifiable risk factors, with combined efforts from clinicians, HIV-infected individuals, and the community.

Author: Johnson, Lisette, Jacobson, Lisa P., Visscher, Barbara, Chenglong Liu, Ostrow, David, Silvestre, Anthony
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2006
Analysis, Drug therapy, Quality of life, Highly active antiretroviral therapy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


The relationship between methamphetamine and popper use and risk of HIV seroconversion in the Multicenter AIDS Cohort Study

Article Abstract:

Longitudinal data from the Multicenter AIDS Cohort Study is used to examine the association between methamphetamine use and HIV seroconversion for men who have sex with men (MSM). The examination of the mechanisms underlying the synergism of drug use and sexual risk behaviors on rates of HIV seroconversion is required for developing new-targeted HIV prevention strategies for nonmonogamous drug-using MSM.

Author: Cox, Christopher, Ostrow, David G., Jacobson, Lisa P., Stall, Ron, Xiuhong Li, Plankey, Michael W., Peck, James A.
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2007
Complications and side effects, Risk factors, Drug abuse, HIV seropositivity, HIV positive, Clinical report

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Estimates of HIV incidence among persons testing for HIV using the sensitive/less sensitive enzyme immunoassy, New York City, 2001

Article Abstract:

An investigation is conducted to estimate the incidence of HIV infection among persons testing for HIV in New York City. The results revealed that male injection drug users (IDUs) and men who have sex with men (MSM) might be good candidates for intensified targeting of HIV prevention resources in New York City.

Author: Nash, Denis, Torian, Lucia, Bennani, Yussef, Ramaswamy, Chitra
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2005
New York, Prevention

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Health aspects, HIV infection, HIV infections, Gays, Drug use
Similar abstracts:
  • Abstracts: Predictors of mortality in a cohort of HIV-1-infected adults in rural Africa. High plasma level of interleukin-18 in HIV-infected subjects with lipodystrophy
  • Abstracts: Risk Factors for Pilot Fatalities in General Aviation Airplane Crash Landings. Effect of a clinic-based referral system to head start: a randomized controlled trial
  • Abstracts: The evidence on quality of life for older people. Making life better for older people. West Nile virus
  • Abstracts: Does exposure to antiretroviral therapy affect growth in the first 18 months of life in uninfected children born to HIV-infected women?
  • Abstracts: Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. CCR5 and CXCR4 expression on memory and naive T cells in HIV-1 infection and response to highly active antiretroviral therapy
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.